Fangzhou Inc. 6086
HKEX · Hong Kong SAR China · Retail Trade
HKD 0.8500+0.03 (+3.03%)
Market closed· · HKD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · HKD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
SHANGHAI, China, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, has released its 2026 interim report, highlighting continued progress in its “AI + Chronic Disease Services” strategy as the Company advances its positioning as a full-lifecycle personal health service partner. In the first half of 2026, Fangzhou recorded revenue of RMB1.8245 billion, up 22.2% year-on-year, while adjusted ne
SHANGHAI, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, announced today that its “AI + Chronic Care” platform has been named to the 2026 Fortune China Best Designs list, recognizing the Company’s innovation and application of artificial intelligence in chronic disease management. Fangzhou’s AI-Powered Chronic Care Model Named to Fortune China’s Best Designs 2026 Now in its fifth year, F
HONG KONG, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, announced its interim results for the six months ended June 30, 2026, reporting revenue of RMB 1.8245 billion, a 22.2% year-on-year increase, and adjusted net profit of RMB 18.7 million, up 6.4% from the same period last year. The results reflect the Company’s continued execution of its "AI + chronic care" strategy amid favorable p
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.